ReviewWorld journal of clinical oncology2020

Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?

Pedro Bargão Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.